ACAD
NASDAQStockACADIA Pharmaceuticals Inc.
$21.33-0.65 (-2.96%)
52-Week Range
$14.10
$28.06
Key Stats
Market Cap
3.6B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.81
Volume
744.9K
Avg Volume
2.0M
Performance
1M
-6.30%
3M
-21.66%
6M
-13.78%
YTD
-19.09%
1Y
+26.83%
3Y
+9.58%
5Y
-29.08%
Price Chart
ETF Exposure
ACAD is held by 136 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| IBRN | iShares Neuroscience and Healthcare ETF | 3.30% |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 3.01% |
| PBE | Invesco Biotechnology & Genome ETF | 2.62% |
| SBIO | ALPS Medical Breakthroughs ETF | 2.45% |
| MNTL | Tema Neuroscience And Mental Health ETF | 2.42% |
| ASCE | Allspring SMID Core ETF | 1.86% |
| PSCH | Invesco S&P SmallCap Health Care ETF | 1.71% |
| BBP | Virtus Biotech ETF | 1.27% |
| RZG | Invesco S&P SmallCap 600 Pure Growth ETF | 1.21% |
| GRPZ | Invesco S&P SmallCap 600 GARP ETF | 1.06% |
| XBI | State Street SPDR S&P Biotech ETF | 0.94% |
| FSML | Franklin Small Cap Enhanced ETF | 0.89% |
| ROSC | Hartford Multifactor Small Cap ETF | 0.63% |
| XSHQ | Invesco S&P SmallCap Quality ETF | 0.62% |
| FNY | First Trust Mid Cap Growth AlphaDEX Fund | 0.61% |
| ACSG | American Century Small Cap Growth Insights ETF | 0.47% |
| FLQS | Franklin U.S. Small Cap Multifactor Index ETF | 0.45% |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 0.40% |
| AGNG | Global X - Aging Population ETF | 0.39% |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 0.37% |
| SLYG | State Street SPDR S&P 600 Small Cap Growth ETF | 0.36% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 0.35% |
| SQLV | Royce Quant Small-Cap Quality Value ETF | 0.33% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.33% |
| IBB | iShares Biotechnology ETF | 0.33% |
| VFQY | Vanguard U.S. Quality Factor ETF | 0.30% |
| ESIX | State Street SPDR S&P SmallCap 600 ESG ETF | 0.29% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.29% |
| FNX | First Trust Mid Cap Core AlphaDEX Fund | 0.24% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.24% |
| USVM | VictoryShares US Small Mid Cap Value Momentum ETF | 0.24% |
| BFOR | Barron's 400SM ETF | 0.22% |
| IWO | iShares Russell 2000 Growth ETF | 0.22% |
| XJR | iShares ESG Select Screened S&P Small-Cap ETF | 0.22% |
| PWS | Pacer WealthShield ETF | 0.22% |
| VIOO | Vanguard S&P Small-Cap 600 ETF | 0.20% |
| QVMS | Invesco S&P SmallCap 600 QVM Multi-factor ETF | 0.20% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.20% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.20% |
| PSC | Principal U.S. Small-Cap Multi-Factor ETF | 0.20% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.19% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.19% |
| SPSM | State Street SPDR Portfolio S&P 600 Small Cap ETF | 0.19% |
| IJR | iShares Core S&P Small-Cap ETF | 0.18% |
| LNGR | Global X Aging Population ETF | 0.18% |
| BKSE | BNY Mellon US Small Cap Core Equity ETF | 0.18% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.16% |
| DFAS | Dimensional - US Small Cap ETF | 0.16% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.15% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.14% |
Page 1 of 3Next
About ACAD ETF Exposure
ACADIA Pharmaceuticals Inc. (ACAD) is held by 136 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 3.6B, ACAD is a widely held institutional stock. The stock currently trades at $21.33. Investors can gain exposure to ACAD through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ACAD, sorted by portfolio weight.